{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040465","form_type":"8-K","ticker":"IBO","cik":"0001834105","company_name":"IMPACT BIOMEDICAL INC.","filed_at":"2024-10-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.918996+00:00","generated_at":"2026-05-30T18:15:09.377568+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Impact Biomedical enters three-year CEO employment agreement with Frank Heuszel","bullets":["Term from Oct 3, 2024 to Oct 3, 2027; base salary $200K year 1, $250K years 2 and 3.","Mandatory bonus: $150K year 1, $100K each year 2 and 3; discretionary bonuses eligible.","Option grant of 300,000 shares at $3.00/share under 2023 Equity Incentive Plan.","Agreement defines termination for cause and good reason; executive remains CEO, Chairman, President."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040465","json":"https://secwatch.observer/filing/0001493152-24-040465.json","markdown":"https://secwatch.observer/filing/0001493152-24-040465.md","text":"https://secwatch.observer/filing/0001493152-24-040465.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224040465/0001493152-24-040465-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1834105/000149315224040465/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T18:15:09.377568+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}